Clinical Trial Update: Implementation of Onsite Rapid CYP2C19 Assay for Genotype Guided Dual Antiplatelet Therapy After Acute Ischemic Stroke

View source ↗

Summary

Clinical trial update describing the implementation of an onsite rapid CYP2C19 assay to guide dual antiplatelet therapy after acute ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: University of Virginia | Conditions: Ischemic Stroke, CYP2C19 Polymorphism | Status: RECRUITING